• Home
  • Outline
  • Members
  • Report
  • Contact

Outline

Outline

Mission: to “realize the application of human iPSC-derived cardiomyocytes, hepatocytes and neurons for drug safety evaluations by both technological advancement and including policy recommendations.”

Organizational structure

Organizational structure

An Executive Committee

Consortium Leader Norimasa Miyamoto, Ph.D. (Eisai Co., Ltd.)
Cardiomyocyte Team Leader Kiyoshi Takashuna, Ph.D. (Axcelead Drug Discovery Partners Inc.)
Neuron Team Leader Takafumi Shirakawa, Ph.D. (Astellas Pharma Inc.)
Neuron Team Subleader Takuya Kondo, Ph.D. (TAIHO PHARMACEUTICAL CO., LTD.)
Neuron Team in vivo Group Leader Kaoru Morimura, Ph.D. (FUJIFILM Corporation)
Neuron Team Data Analysis Group Leader Takayoshi Matsubara (PerkinElmer Japan Co., Ltd.)
Cell Characterization Team Leader Tadahiro Shinozawa, Ph.D. (Takeda Pharmaceutical Company Limited)
Information Sharing Leader Tomoharu Osada, Ph.D.(LSI Medience Corporation)
Information Sharing Subleader Atsuko Ojima(TechnoPro, Inc. TechnoPro R&D, Company)
  • Japan iPS Cardiac Safety Assessment (JiCSA)
  • Introduction of UK Scotland life science
Page Top